Simultaneous robot-assisted bilateral partial nephrectomy and radical prostatectomy

Introduction. Simultaneous robot‑assisted procedures for synchronous tumours of different anatomical sites remain rare in routine clinical practice. We report a clinical case of successful simultaneous robot‑assisted bilateral partial nephrectomy and radical prostatectomy in a patient with synchronous bilateral renal cell carcinoma and prostate cancer.

Case report. A 74‑year‑old man with synchronous renal cell carcinoma in both kidneys and localised prostate cancer underwent a single‑session operation consisting of robot‑assisted bilateral partial nephrectomy and radical prostatectomy with extended pelvic lymph node dissection. To minimise operative time and the risk of complications, patient positioning, trocar placement, and the sequence of surgical steps were carefully optimised. The total operative time was 340 minutes, including 230 minutes of console time; no intraoperative complications occurred and blood loss was less than 100 ml. The postoperative course was uneventful, and the patient was discharged on postoperative day 4. Histopathological examination revealed papillary renal cell carcinoma (G2) in the right kidney, clear cell renal cell carcinoma in the left kidney, and acinar adenocarcinoma of the prostate (Gleason score 7 (3+4)), with negative surgical margins in all specimens. At 1‑month follow‑up, there were no signs of recurrence or procedure‑related complications, and the patient reported no urinary incontinence.

Conclusion. This case illustrates the feasibility and safety of simultaneous robot‑assisted surgery in patients with synchronous renal and prostate tumours. The described approach allows favourable oncological and functional outcomes, shortens hospital stay, and minimises the risk of complications, and may serve as a practical reference for surgeons planning similar procedures.

1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263. DOI: 10.3322/caac.21834

2. Zhang Y, Chen J, Xu L, Hu X, Zeng H, Liu Z. Case report: Synchronous prostate cancer and renal cell carcinoma with prostate cancer-origin metastases to adrenal and renal hilar lymph nodes. Front Oncol. 2024;14:1412067. DOI: 10.3389/fonc.2024.1412067

3. Salhab RQ, Ghazaleh ZI, Barbarawi W, Salah-Aldin R, Hour H, Sweity R, Bakri IA. An unusual occurrence of multiple primary malignant neoplasms: a case report and narrative review. Front Oncol. 2024;14:1381532. DOI: 10.3389/fonc.2024.1381532

4. Vogt A, Schmid S, Heinimann K, Frick H, Herrmann C, Cerny T, Omlin A. Multiple primary tumours: challenges and approaches, a review. ESMO Open. 2017;2(2):e000172. DOI: 10.1136/esmoopen-2017-000172

5. Corvino A, Setola SV, Sandomenico F, Corvino F, Catalano O. Synchronous tumours detected during cancer patient staging: prevalence and patterns of occurrence in multidetector computed tomography. Pol J Radiol. 2020;85:e261-e270. DOI: 10.5114/pjr.2020.95781

6. Akpinar C, Suer E, Turkolmez K, Beduk Y. Combined Robotic-assisted Laparoscopic Radical Prostatectomy and Partial Nephrectomy, Rare Coincidence. Urology. 2019;128:1-4. DOI: 10.1016/j.urology.2019.02.031

7. Ozsoy O, Fioretta G, Ares C, Miralbell R. Incidental detection of synchronous primary tumours during staging workup for prostate cancer. Swiss Med Wkly. 2010;140(15-16):233-236. DOI: 10.4414/smw.2010.12976

8. Antonelli A, Calza S, Arrighi N, Zani D, Corti S, Cozzoli A, Zanotelli T, Cunico SC, Simeone C. Clinical features and prognosis of patients with renal cancer and a second malignancy. Urol Oncol. 2012;30(3):294-300. DOI: 10.1016/j.urolonc.2010.04.013

9. Chakraborty S, Tarantolo SR, Batra SK, Hauke RJ. Incidence and prognostic significance of second primary cancers in renal cell carcinoma. Am J Clin Oncol. 2013;36(2):132-142. DOI: 10.1097/COC.0b013e3182438ddf

10. Beisland C, Talleraas O, Bakke A, Norstein J. Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study. BJU Int. 2006;97(4):698-702. DOI: 10.1111/j.1464-410X.2006.06004.x

11. Thompson RH, Leibovich BC, Cheville JC, Webster WS, Lohse CM, Kwon ED, Zincke H, Blute ML. Second primary malignancies associated with renal cell carcinoma histological subtypes. J Urol. 2006;176(3):900- 903; discussion 903-904. DOI: 10.1016/j.juro.2006.04.080

12. Liu H, Hemminki K, Sundquist J. Renal cell carcinoma as first and second primary cancer: etiological clues from the Swedish Family-Cancer Database. J Urol. 2011;185(6):2045-2049. DOI: 10.1016/j.juro.2011.02.001

13. Reva S.A., Arnautov A.V., Nosov A.K., Berkut M.V., Petrov S.B., Belyaev A.M. The impact of the time interval from diagnosis to radical prostatectomy on oncological outcomes in high-risk prostate cancer. Urology Herald. 2022;10(3):44-53. (In Russian). DOI: 10.21886/2308-6424-2022-10-3-44-53.

14. Boncher N, Vricella G, Greene G, Madi R. Concurrent robotic renal and prostatic surgery: initial case series and safety data of a new surgical technique. J Endourol. 2010;24(10):1625-1629. DOI: 10.1089/end.2010.0151

15. Patel MN, Eun D, Menon M, Rogers CG. Combined robotic-assisted laparoscopic partial nephrectomy and radical prostatectomy. JSLS. 2009;13(2):229-232. PMID: 19660223; PMCID: PMC3015919

16. Gallyamov E.A., Lutsevich O.E., Popov S.V., Senderovich E.I., Presnov K.S., Kochkin A.D., Sergeev V.P., Nasirova N.I., Mikhaylikov T.G., Aminova L.N., Gallyamova S.V., Novikov A.B. Simulatneous Laparosopic Operations. Clin. Experiment. Surg. Petrovsky J. 2014;(3):70-77. (In Russian).

17. Jung JH, Arkoncel FR, Lee JW, Oh CK, Yusoff NA, Kim KJ, Rha KH. Initial clinical experience of simultaneous robot-assisted bilateral partial nephrectomy and radical prostatectomy. Yonsei Med J. 2012;53(1):236- 239. DOI: 10.3349/ymj.2012.53.1.236